GDUFA

Over the past week, analysts at  Jefferies have been holding meetings with senior executives from 29 specialty pharmaceutical (21 branded, eight generic) companies. Following the discussions, here are the main takeaways. Following its busiest year ever for acquisitions, the industry will...